Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Overviewing Real-World Outcomes to Boost Interventional Management of CAlcified Coronary Lesions: the OROBICA Registry.

NCT07566403 is registered in ClinicalTrials.gov with Papa Giovanni XXIII Hospital as lead sponsor.

NCT NCT07566403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07566403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Overviewing Real-World Outcomes to Boost Interventional Management of CAlcified Coronary Lesions: the OROBICA Registry.
Lead sponsor
Papa Giovanni XXIII Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
June 30, 2036
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

calcific coronary arteriosclerosis, coronary artery disease (cad), intravascular lithotripsy; rotational atherectomy; ofdi, intravascular ultrasound, optical coherence tomography (oct), orbital atherectomy, percutaneous coronary intervention